Abstract:Streptococcus pneumoniae is an important and frequently carried respiratory pathogen that has the potential to cause serious invasive diseases, such as pneumonia, meningitis, and sepsis. Young children and older adults are among the most vulnerable to developing serious disease. With the arrival of the COVID-19 pandemic and the concomitant restrictive measures, invasive disease cases caused by respiratory bacterial species, including pneumococci, decreased substantially. Notably, the stringency of the containm… Show more
“…Studies in Belgium and Israel found no substantive reductions in prevalence pre- and post-NPIs, although in both our study and the Israel study pneumococcal prevalence was lower in one of the two time periods assessed. [4,5] Importantly, we observed a substantial decline in overall and capsular pneumococcal carriage density after the implementation of NPIs. In contrast, the Israel study found no difference in pneumococcal density pre- and post-NPI implementation.…”
Section: Discussionmentioning
confidence: 79%
“…[2–4] Only two studies have examined the impact of NPIs on pneumococcal carriage prevalence. [4,5] No substantive differences in carriage prevalence were observed in children pre- and post-implementation of NPIs in Belgium and Israel, but a decline in the prevalence of respiratory viruses was temporally associated with a decline in IPD in the Israel study. [4] Respiratory viruses increase pneumococcal carriage density, which contributes to transmission and disease.…”
Non-pharmaceutical interventions (NPIs) implemented to contain SARS-CoV-2 have decreased invasive pneumococcal disease. We undertook an observational study to evaluate the impact of NPIs on pneumococcal carriage and density, drivers of transmission and disease, during the COVID-19 pandemic in Ho Chi Minh City, Vietnam. While NPIs did not significantly impact pneumococcal carriage, mean capsular pneumococcal density decreased by up to 91.5% (1.07 log10genome equivalents/mL, 95% Confidence Interval: 0.74-1.41) after NPI introduction compared with the pre-COVID-19 period. As higher pneumococcal density is a risk factor for disease, the observed decline provides a plausible mechanism for the reductions in invasive pneumococcal disease.
“…Studies in Belgium and Israel found no substantive reductions in prevalence pre- and post-NPIs, although in both our study and the Israel study pneumococcal prevalence was lower in one of the two time periods assessed. [4,5] Importantly, we observed a substantial decline in overall and capsular pneumococcal carriage density after the implementation of NPIs. In contrast, the Israel study found no difference in pneumococcal density pre- and post-NPI implementation.…”
Section: Discussionmentioning
confidence: 79%
“…[2–4] Only two studies have examined the impact of NPIs on pneumococcal carriage prevalence. [4,5] No substantive differences in carriage prevalence were observed in children pre- and post-implementation of NPIs in Belgium and Israel, but a decline in the prevalence of respiratory viruses was temporally associated with a decline in IPD in the Israel study. [4] Respiratory viruses increase pneumococcal carriage density, which contributes to transmission and disease.…”
Non-pharmaceutical interventions (NPIs) implemented to contain SARS-CoV-2 have decreased invasive pneumococcal disease. We undertook an observational study to evaluate the impact of NPIs on pneumococcal carriage and density, drivers of transmission and disease, during the COVID-19 pandemic in Ho Chi Minh City, Vietnam. While NPIs did not significantly impact pneumococcal carriage, mean capsular pneumococcal density decreased by up to 91.5% (1.07 log10genome equivalents/mL, 95% Confidence Interval: 0.74-1.41) after NPI introduction compared with the pre-COVID-19 period. As higher pneumococcal density is a risk factor for disease, the observed decline provides a plausible mechanism for the reductions in invasive pneumococcal disease.
“…However, data from the few studies that have addressed this issue to date suggest that this does not seem to be the case. In Belgium and Israel, the prevalence of pneumococcal carriage in children aged <3 years was either unchanged during the pandemic or was only reduced slightly, although the IPD rates decreased markedly in the same age group ( Danino et al., 2021 ; Willen et al., 2022 ), Moreover, in Israel, colonization density and pneumococcal serotype distributions were similar to previous years ( Danino et al., 2021 ). The present study did not find a decline in pneumococcal carriage rates among children aged 24–60 months during the COVID-19 pandemic, but instead found a significant increase in rates in 2020 that remained high to June 2021.…”
“…It was initially assumed that the reduction in the incidence of IPD was due to reduced transmission of the bacteria resulting from the implementation of non-pharmaceutical interventions. Pneumococcus is commonly carried in the upper respiratory tract of young children, however, the prevalence of pneumococcal carriage in children was near normal levels during 2020-2021 [3,8]. This demonstrates that children were still being exposed to and acquiring pneumococcus but not getting sick.…”
Background. Reported rates of invasive pneumococcal disease were markedly lower than normal during the 2020/2021 winter in the Northern Hemisphere, the first year after the start of the COVID-19 pandemic. However, little is known about rates of carriage of pneumococcus among adults during this period.
Methods. Between October 2020-August 2021, couples living in the Greater New Haven Area were enrolled if both individuals were aged 60 years and above and did not have any individuals under the age of 60 years living in the household. Saliva samples and questionnaires regarding social activities and contacts and medical history were obtained every 2 weeks for a period of 10 weeks. Following culture-enrichment, extracted DNA was tested using qPCR for pneumococcus-specific sequences piaB and lytA. Individuals were considered positive for pneumococcal carriage when Ct-values for piaB were less than 40.
Results. We collected 567 saliva samples from 95 individuals aged 60 years and above (47 household pairs and one singleton). Of those, 7.1% of samples tested positive for pneumococcus by either piaB only (n=6) or both piaB and lytA (n=34), representing 22/95 (23.2%) individuals and 16/48 (33.3%) households over the course of the 10-week study period. Study participants attended few social events during this period. However, many participants continued to have regular contact with children. Individuals who had regular contact with preschool and school aged children (i.e., 2-9 year olds) had a higher prevalence of carriage (15.9% vs 5.4%).
Conclusions. Despite COVID-19-related disruptions, a large proportion of older adults carried pneumococcus at least once during the 10-week study period. Prevalence was particularly high among those who had contact with school-aged children, but carriage was not limited to this group.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.